We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSDT icon
4201
Solana Company
HSDT
$96.3M
0
SILV
4202
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$277K ﹤0.01%
31,663
LDTC
4203
DELISTED
LeddarTech
LDTC
$275K ﹤0.01%
56,764
+22,248
+64% +$109K
HTGM
4204
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$273K ﹤0.01%
3,928
+1,009
+35% +$54.6K
BNBX
4205
DELISTED
BNB PLUS CORP
BNBX
$272K ﹤0.01%
3
+1
+50% +$97.5K
AVDL
4206
DELISTED
Avadel Pharmaceuticals
AVDL
$272K ﹤0.01%
40,528
-1,917
-5% -$15.2K
AEG icon
4207
Aegon
AEG
$14B
$271K ﹤0.01%
70,025
-146
-0.2% -$622
TASK icon
4208
TaskUs
TASK
$556M
$271K ﹤0.01%
+7,927
New +$250K
NGD
4209
DELISTED
New Gold Inc
NGD
$270K ﹤0.01%
150,508
SNGX icon
4210
Soligenix
SNGX
$5.54M
$270K ﹤0.01%
1,018
+107
+12% +$31.4K
SYM icon
4211
Symbotic
SYM
$5.48B
$270K ﹤0.01%
27,183
+14,324
+111% +$144K
IFS icon
4212
Intercorp Financial Services
IFS
$6.48B
$269K ﹤0.01%
10,730
-1,770
-14% -$48.8K
EVOK
4213
DELISTED
Evoke Pharma
EVOK
$268K ﹤0.01%
1,359
+248
+22% +$53.1K
LKFT
4214
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$268K ﹤0.01%
3,895
-925
-19% -$70.5K
EPHY
4215
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$268K ﹤0.01%
27,590
+11,640
+73% +$114K
SRTS icon
4216
Sensus Healthcare
SRTS
$47.9M
$266K ﹤0.01%
69,332
+10,616
+18% +$39.8K
GWH icon
4217
ESS Tech
GWH
$22M
$264K ﹤0.01%
+1,779
New +$264K
PNRG icon
4218
PrimeEnergy Resources
PNRG
$298M
$264K ﹤0.01%
5,719
-3,112
-35% -$141K
PFIE
4219
DELISTED
Profire Energy, Inc
PFIE
$264K ﹤0.01%
234,396
IO
4220
DELISTED
ION Geophysical Corporation
IO
$264K ﹤0.01%
126,736
+45,440
+56% +$97.6K
CMPS
4221
Compass Pathways
CMPS
$1.53B
$263K ﹤0.01%
6,895
+794
+13% +$28.4K
ATAXZ
4222
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$263K ﹤0.01%
39,141
SIF icon
4223
SIFCO Industries
SIF
$161M
$262K ﹤0.01%
26,099
+4,174
+19% +$49.2K
BBEU icon
4224
JPMorgan BetaBuilders Europe ETF
BBEU
$9.35B
0
GOVX icon
4225
GeoVax Labs
GOVX
$3.55M
$261K ﹤0.01%
140
+40
+40% +$77.8K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.